Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 136

1.

TCF-1 limits the formation of Tc17 cells via repression of the MAF-RORγt axis.

Mielke LA, Liao Y, Clemens EB, Firth MA, Duckworth B, Huang Q, Almeida FF, Chopin M, Koay HF, Bell CA, Hediyeh-Zadeh S, Park SL, Raghu D, Choi J, Putoczki TL, Hodgkin PD, Franks AE, Mackay LK, Godfrey DI, Davis MJ, Xue HH, Bryant VL, Kedzierska K, Shi W, Belz GT.

J Exp Med. 2019 Jul 1;216(7):1682-1699. doi: 10.1084/jem.20181778. Epub 2019 May 29.

2.

Quantifying NK cell growth and survival changes in response to cytokines and regulatory checkpoint blockade helps identify optimal culture and expansion conditions.

Hennessy RJ, Pham K, Delconte R, Rautela J, Hodgkin PD, Huntington ND.

J Leukoc Biol. 2019 Jun;105(6):1341-1354. doi: 10.1002/JLB.MA0718-296R. Epub 2019 May 12.

PMID:
31079418
3.

Fatal Enteroviral Encephalitis in a Patient with Common Variable Immunodeficiency Harbouring a Novel Mutation in NFKB2.

Slade CA, McLean C, Scerri T, Giang TB, Megaloudis S, Strathmore A, Tempany JC, Nicholls K, D'Arcy C, Bahlo M, Hodgkin PD, Douglass JA, Bryant VL.

J Clin Immunol. 2019 Apr;39(3):324-335. doi: 10.1007/s10875-019-00602-x. Epub 2019 Mar 29.

PMID:
30927119
4.

Regulatory T Cells Suppress Effector T Cell Proliferation by Limiting Division Destiny.

Dowling MR, Kan A, Heinzel S, Marchingo JM, Hodgkin PD, Hawkins ED.

Front Immunol. 2018 Oct 30;9:2461. doi: 10.3389/fimmu.2018.02461. eCollection 2018.

5.

Stochastically Timed Competition Between Division and Differentiation Fates Regulates the Transition From B Lymphoblast to Plasma Cell.

Zhou JHS, Markham JF, Duffy KR, Hodgkin PD.

Front Immunol. 2018 Sep 10;9:2053. doi: 10.3389/fimmu.2018.02053. eCollection 2018.

6.

Converse Smith-Martin cell cycle kinetics by transformed B lymphocytes.

Pham K, Kan A, Whitehead L, Hennessy RJ, Rogers K, Hodgkin PD.

Cell Cycle. 2018;17(16):2041-2051. doi: 10.1080/15384101.2018.1511511. Epub 2018 Sep 11.

7.

The Rare Anaphylaxis-Associated FcγRIIa3 Exhibits Distinct Characteristics From the Canonical FcγRIIa1.

Anania JC, Trist HM, Palmer CS, Tan PS, Kouskousis BP, Chenoweth AM, Kent SJ, Mackay GA, Hoi A, Koelmeyer R, Slade C, Bryant VL, Hodgkin PD, Aui PM, van Zelm MC, Wines BD, Hogarth PM.

Front Immunol. 2018 Aug 20;9:1809. doi: 10.3389/fimmu.2018.01809. eCollection 2018.

8.

Modifying clonal selection theory with a probabilistic cell.

Hodgkin PD.

Immunol Rev. 2018 Sep;285(1):249-262. doi: 10.1111/imr.12695. Review.

9.

Multiplexed Division Tracking Dyes for Proliferation-Based Clonal Lineage Tracing.

Horton MB, Prevedello G, Marchingo JM, Zhou JHS, Duffy KR, Heinzel S, Hodgkin PD.

J Immunol. 2018 Aug 1;201(3):1097-1103. doi: 10.4049/jimmunol.1800481. Epub 2018 Jun 18.

10.

Delayed Diagnosis and Complications of Predominantly Antibody Deficiencies in a Cohort of Australian Adults.

Slade CA, Bosco JJ, Binh Giang T, Kruse E, Stirling RG, Cameron PU, Hore-Lacy F, Sutherland MF, Barnes SL, Holdsworth S, Ojaimi S, Unglik GA, De Luca J, Patel M, McComish J, Spriggs K, Tran Y, Auyeung P, Nicholls K, O'Hehir RE, Hodgkin PD, Douglass JA, Bryant VL, van Zelm MC.

Front Immunol. 2018 May 14;9:694. doi: 10.3389/fimmu.2018.00694. eCollection 2018.

11.

DiSNE Movie Visualization and Assessment of Clonal Kinetics Reveal Multiple Trajectories of Dendritic Cell Development.

Lin DS, Kan A, Gao J, Crampin EJ, Hodgkin PD, Naik SH.

Cell Rep. 2018 Mar 6;22(10):2557-2566. doi: 10.1016/j.celrep.2018.02.046.

12.

The regulation of lymphocyte activation and proliferation.

Heinzel S, Marchingo JM, Horton MB, Hodgkin PD.

Curr Opin Immunol. 2018 Apr;51:32-38. doi: 10.1016/j.coi.2018.01.002. Epub 2018 Feb 3. Review.

PMID:
29414529
13.

Superior properties of CellTrace Yellow™ as a division tracking dye for human and murine lymphocytes.

Tempany JC, Zhou JH, Hodgkin PD, Bryant VL.

Immunol Cell Biol. 2018 Feb;96(2):149-159. doi: 10.1111/imcb.1020. Epub 2017 Dec 15.

14.

Epistatic interactions between mutations of TACI (TNFRSF13B) and TCF3 result in a severe primary immunodeficiency disorder and systemic lupus erythematosus.

Ameratunga R, Koopmans W, Woon ST, Leung E, Lehnert K, Slade CA, Tempany JC, Enders A, Steele R, Browett P, Hodgkin PD, Bryant VL.

Clin Transl Immunology. 2017 Oct 20;6(10):e159. doi: 10.1038/cti.2017.41. eCollection 2017 Oct.

15.

Life, death, and antibodies.

Bryant VL, Hodgkin PD.

Science. 2017 Oct 13;358(6360):171-172. doi: 10.1126/science.aap8728. No abstract available.

PMID:
29026032
16.

The TNF Receptor Superfamily-NF-κB Axis Is Critical to Maintain Effector Regulatory T Cells in Lymphoid and Non-lymphoid Tissues.

Vasanthakumar A, Liao Y, Teh P, Pascutti MF, Oja AE, Garnham AL, Gloury R, Tempany JC, Sidwell T, Cuadrado E, Tuijnenburg P, Kuijpers TW, Lalaoui N, Mielke LA, Bryant VL, Hodgkin PD, Silke J, Smyth GK, Nolte MA, Shi W, Kallies A.

Cell Rep. 2017 Sep 19;20(12):2906-2920. doi: 10.1016/j.celrep.2017.08.068. Epub 2017 Sep 7.

17.

Cognate antigen engagement on parenchymal cells stimulates CD8+ T cell proliferation in situ.

Sutherland RM, Londrigan SL, Brady JL, Carrington EM, Marchingo JM, Heinzel S, Hodgkin PD, Graham KL, Kay TW, Zhan Y, Lew AM.

Nat Commun. 2017 Apr 12;8:14809. doi: 10.1038/ncomms14809.

18.

Cell cycle progression dictates the requirement for BCL2 in natural killer cell survival.

Viant C, Guia S, Hennessy RJ, Rautela J, Pham K, Bernat C, Goh W, Jiao Y, Delconte R, Roger M, Simon V, Souza-Fonseca-Guimaraes F, Grabow S, Belz GT, Kile BT, Strasser A, Gray D, Hodgkin PD, Beutler B, Vivier E, Ugolini S, Huntington ND.

J Exp Med. 2017 Feb;214(2):491-510. doi: 10.1084/jem.20160869. Epub 2017 Jan 5.

19.

Comparative evaluation of performance measures for shading correction in time-lapse fluorescence microscopy.

Liu L, Kan A, Leckie C, Hodgkin PD.

J Microsc. 2017 Apr;266(1):15-27. doi: 10.1111/jmi.12512. Epub 2016 Dec 21.

PMID:
28000921
20.

T-cell stimuli independently sum to regulate an inherited clonal division fate.

Marchingo JM, Prevedello G, Kan A, Heinzel S, Hodgkin PD, Duffy KR.

Nat Commun. 2016 Nov 21;7:13540. doi: 10.1038/ncomms13540.

21.

A Myc-dependent division timer complements a cell-death timer to regulate T cell and B cell responses.

Heinzel S, Binh Giang T, Kan A, Marchingo JM, Lye BK, Corcoran LM, Hodgkin PD.

Nat Immunol. 2017 Jan;18(1):96-103. doi: 10.1038/ni.3598. Epub 2016 Nov 7.

PMID:
27820810
22.

Autoreactive T cells in chronic spontaneous urticaria target the IgE Fc receptor Iα subunit.

Auyeung P, Mittag D, Hodgkin PD, Harrison LC.

J Allergy Clin Immunol. 2016 Sep;138(3):761-768.e4. doi: 10.1016/j.jaci.2016.04.036. Epub 2016 Jun 8.

PMID:
27417022
23.

Regulation of platelet lifespan in the presence and absence of thrombopoietin signaling.

Lebois M, Dowling MR, Gangatirkar P, Hodgkin PD, Kile BT, Alexander WS, Josefsson EC.

J Thromb Haemost. 2016 Sep;14(9):1882-7. doi: 10.1111/jth.13397. Epub 2016 Aug 11.

24.

Dynamic changes in Id3 and E-protein activity orchestrate germinal center and plasma cell development.

Gloury R, Zotos D, Zuidscherwoude M, Masson F, Liao Y, Hasbold J, Corcoran LM, Hodgkin PD, Belz GT, Shi W, Nutt SL, Tarlinton DM, Kallies A.

J Exp Med. 2016 May 30;213(6):1095-111. doi: 10.1084/jem.20152003. Epub 2016 May 23.

25.

NFκB1 is essential to prevent the development of multiorgan autoimmunity by limiting IL-6 production in follicular B cells.

de Valle E, Grigoriadis G, O'Reilly LA, Willis SN, Maxwell MJ, Corcoran LM, Tsantikos E, Cornish JK, Fairfax KA, Vasanthakumar A, Febbraio MA, Hibbs ML, Pellegrini M, Banerjee A, Hodgkin PD, Kallies A, Mackay F, Strasser A, Gerondakis S, Gugasyan R.

J Exp Med. 2016 Apr 4;213(4):621-41. doi: 10.1084/jem.20151182. Epub 2016 Mar 28.

26.

Stochastic Measurement Models for Quantifying Lymphocyte Responses Using Flow Cytometry.

Kan A, Pavlyshyn D, Markham JF, Dowling MR, Heinzel S, Zhou JH, Marchingo JM, Hodgkin PD.

PLoS One. 2016 Jan 7;11(1):e0146227. doi: 10.1371/journal.pone.0146227. eCollection 2016.

27.

Shedding light on cell cycle control by T and B lymphocytes.

Kinjyo I, Weninger W, Hodgkin PD.

Cell Cycle. 2015 Aug 3;14(15):2381-2. doi: 10.1080/15384101.2015.1063291. Epub 2015 Jul 1. No abstract available.

28.

Transcriptional profiling of mouse B cell terminal differentiation defines a signature for antibody-secreting plasma cells.

Shi W, Liao Y, Willis SN, Taubenheim N, Inouye M, Tarlinton DM, Smyth GK, Hodgkin PD, Nutt SL, Corcoran LM.

Nat Immunol. 2015 Jun;16(6):663-73. doi: 10.1038/ni.3154. Epub 2015 Apr 20.

PMID:
25894659
29.

No luck replicating the immune response in twins.

Baxter AG, Hodgkin PD.

Genome Med. 2015 Mar 25;7(1):29. doi: 10.1186/s13073-015-0156-0. eCollection 2015.

30.

Real-time tracking of cell cycle progression during CD8+ effector and memory T-cell differentiation.

Kinjyo I, Qin J, Tan SY, Wellard CJ, Mrass P, Ritchie W, Doi A, Cavanagh LL, Tomura M, Sakaue-Sawano A, Kanagawa O, Miyawaki A, Hodgkin PD, Weninger W.

Nat Commun. 2015 Feb 24;6:6301. doi: 10.1038/ncomms7301.

31.

The generation of antibody-secreting plasma cells.

Nutt SL, Hodgkin PD, Tarlinton DM, Corcoran LM.

Nat Rev Immunol. 2015 Mar;15(3):160-71. doi: 10.1038/nri3795. Epub 2015 Feb 20. Review.

PMID:
25698678
32.

T cell signaling. Antigen affinity, costimulation, and cytokine inputs sum linearly to amplify T cell expansion.

Marchingo JM, Kan A, Sutherland RM, Duffy KR, Wellard CJ, Belz GT, Lew AM, Dowling MR, Heinzel S, Hodgkin PD.

Science. 2014 Nov 28;346(6213):1123-7. doi: 10.1126/science.1260044.

33.

The transcription factors IRF8 and PU.1 negatively regulate plasma cell differentiation.

Carotta S, Willis SN, Hasbold J, Inouye M, Pang SH, Emslie D, Light A, Chopin M, Shi W, Wang H, Morse HC 3rd, Tarlinton DM, Corcoran LM, Hodgkin PD, Nutt SL.

J Exp Med. 2014 Oct 20;211(11):2169-81. doi: 10.1084/jem.20140425. Epub 2014 Oct 6.

34.

Why the immune system takes its chances with randomness.

Hodgkin PD, Dowling MR, Duffy KR.

Nat Rev Immunol. 2014 Oct;14(10):711. doi: 10.1038/nri3734-c1. Epub 2014 Sep 12. No abstract available.

PMID:
25212742
35.

Mechanisms of cell division as regulators of acute immune response.

Kan A, Hodgkin PD.

Syst Synth Biol. 2014 Sep;8(3):215-21. doi: 10.1007/s11693-014-9149-3. Epub 2014 Apr 29. Review.

36.

Stretched cell cycle model for proliferating lymphocytes.

Dowling MR, Kan A, Heinzel S, Zhou JH, Marchingo JM, Wellard CJ, Markham JF, Hodgkin PD.

Proc Natl Acad Sci U S A. 2014 Apr 29;111(17):6377-82. doi: 10.1073/pnas.1322420111. Epub 2014 Apr 14.

37.

Determining lineage pathways from cellular barcoding experiments.

Perié L, Hodgkin PD, Naik SH, Schumacher TN, de Boer RJ, Duffy KR.

Cell Rep. 2014 Feb 27;6(4):617-24. doi: 10.1016/j.celrep.2014.01.016. Epub 2014 Feb 6.

38.

Labour-efficient in vitro lymphocyte population tracking and fate prediction using automation and manual review.

Chakravorty R, Rawlinson D, Zhang A, Markham J, Dowling MR, Wellard C, Zhou JH, Hodgkin PD.

PLoS One. 2014 Jan 3;9(1):e83251. doi: 10.1371/journal.pone.0083251. eCollection 2014.

39.

Quantal and graded stimulation of B lymphocytes as alternative strategies for regulating adaptive immune responses.

Hawkins ED, Turner ML, Wellard CJ, Zhou JH, Dowling MR, Hodgkin PD.

Nat Commun. 2013;4:2406. doi: 10.1038/ncomms3406.

40.

Mutually exclusive regulation of T cell survival by IL-7R and antigen receptor-induced signals.

Koenen P, Heinzel S, Carrington EM, Happo L, Alexander WS, Zhang JG, Herold MJ, Scott CL, Lew AM, Strasser A, Hodgkin PD.

Nat Commun. 2013;4:1735. doi: 10.1038/ncomms2719.

41.

A model for studying the hemostatic consumption or destruction of platelets.

Dowling MR, Josefsson EC, Henley KJ, Kile BT, Hodgkin PD.

PLoS One. 2013;8(3):e57783. doi: 10.1371/journal.pone.0057783. Epub 2013 Mar 7.

42.

High rate of antibody secretion is not integral to plasma cell differentiation as revealed by XBP-1 deficiency.

Taubenheim N, Tarlinton DM, Crawford S, Corcoran LM, Hodgkin PD, Nutt SL.

J Immunol. 2012 Oct 1;189(7):3328-38. Epub 2012 Aug 27.

43.

Intracellular competition for fates in the immune system.

Duffy KR, Hodgkin PD.

Trends Cell Biol. 2012 Sep;22(9):457-64. doi: 10.1016/j.tcb.2012.05.004. Epub 2012 Jun 21. Review.

PMID:
22727035
44.

Activation-induced B cell fates are selected by intracellular stochastic competition.

Duffy KR, Wellard CJ, Markham JF, Zhou JH, Holmberg R, Hawkins ED, Hasbold J, Dowling MR, Hodgkin PD.

Science. 2012 Jan 20;335(6066):338-41. doi: 10.1126/science.1213230. Epub 2012 Jan 5.

45.

Affinity thresholds for naive CD8+ CTL activation by peptides and engineered influenza A viruses.

Denton AE, Wesselingh R, Gras S, Guillonneau C, Olson MR, Mintern JD, Zeng W, Jackson DC, Rossjohn J, Hodgkin PD, Doherty PC, Turner SJ.

J Immunol. 2011 Dec 1;187(11):5733-44. doi: 10.4049/jimmunol.1003937. Epub 2011 Oct 28.

46.

The genetic network controlling plasma cell differentiation.

Nutt SL, Taubenheim N, Hasbold J, Corcoran LM, Hodgkin PD.

Semin Immunol. 2011 Oct;23(5):341-9. doi: 10.1016/j.smim.2011.08.010. Epub 2011 Sep 15. Review.

PMID:
21924923
47.

Platelet senescence is regulated by an internal timer, not damage inflicted by hits.

Dowling MR, Josefsson EC, Henley KJ, Hodgkin PD, Kile BT.

Blood. 2010 Sep 9;116(10):1776-8. doi: 10.1182/blood-2009-12-259663. Epub 2010 Jun 7.

48.

High-affinity B cell receptor ligation by cognate antigen induces cytokine-independent isotype switching.

Turner ML, Corcoran LM, Brink R, Hodgkin PD.

J Immunol. 2010 Jun 15;184(12):6592-9. doi: 10.4049/jimmunol.0903437. Epub 2010 May 14.

49.

The effect of correlations on the population dynamics of lymphocytes.

Wellard C, Markham J, Hawkins ED, Hodgkin PD.

J Theor Biol. 2010 May 21;264(2):443-9. doi: 10.1016/j.jtbi.2010.02.019. Epub 2010 Feb 19.

PMID:
20171973
50.

A minimum of two distinct heritable factors are required to explain correlation structures in proliferating lymphocytes.

Markham JF, Wellard CJ, Hawkins ED, Duffy KR, Hodgkin PD.

J R Soc Interface. 2010 Jul 6;7(48):1049-59. doi: 10.1098/rsif.2009.0488. Epub 2010 Jan 6.

Supplemental Content

Loading ...
Support Center